Market Tracker

11/21 4:18pm ET

Celldex Therapeutics Inc (NASDAQ:CLDX)

2.82
Delayed Data
As of 4:00pm ET
 -0.04 / -1.40%
Today’s Change
2.20
Today|||52-Week Range
4.91
-20.34%
Year-to-Date

Today’s Trading

Previous close2.86
Today’s open2.86
Day’s range2.79 - 2.90
Volume728,450
Average volume (3 months)1,407,805
Market cap$388.9M
Dividend yield--
Data as of 4:00pm ET, 11/21/2017

Growth & Valuation

Earnings growth (last year)+3.05%
Earnings growth (this year)+24.93%
Earnings growth (next 5 years)--
Revenue growth (last year)+23.83%
P/E ratioNM
Price/Sales52.96
Price/Book1.30

Competitors

 Today’s
change
Today’s
% change
VCYTVeracyte Inc+0.09+1.41%
OXFDOxford Immunotec Glo...+0.30+2.19%
QTNTQuotient Ltd+0.34+8.06%
TRIBTrinity Biotech PLC-0.08-1.54%
Data as of 4:00pm ET, 11/21/2017

Financials

Next reporting dateMarch 7, 2018
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$6.8M
Annual profit (last year)-$128.5M
Net profit margin-1,894.05%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Anthony S. Marucci
Chief Financial Officer &
Senior Vice President
Sam Martin
Corporate headquarters
Hampton, New Jersey

Forecasts